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Background: Transcription of the ribosomal RNA gene repeats by Pol I occurs in the nucleolus and is a
fundamental step in ribosome biogenesis and protein translation. Due to tight coordination between ribosome
biogenesis and cell proliferation, transcription of rRNA and stable maintenance of rDNA clusters are thought to be
under intricate control by intercalated mechanisms, particularly at the epigenetic level.
Methods and Results: Here we identify the nucleolar protein Myb-binding protein 1a (Mybbp1a) as a novel
negative regulator of rRNA expression. Suppression of rDNA transcription by Mybbp1a was linked to promoter
regulation as illustrated by its binding to the chromatin around the hypermethylated, inactive rDNA gene
promoters. Our data further showed that downregulation of Mybbp1a abrogated the local DNA methylation levels
and histone marks associated with gene silencing, and altered the promoter occupancy of various factors such UBF
and HDACs, consequently leading to elevated rRNA expression. Mechanistically, we propose that Mybbp1a
maintains rDNA repeats in a silenced state while in association with the negative epigenetic modifiers HDAC1/2.
Conclusions: Results from our present work reveal a previously unrecognized co-repressor role of Mybbp1a in
rRNA expression. They are further consistent with the scenario that Mybbp1a is an integral constituent of the rDNA
epigenetic regulation that underlies the balanced state of rDNA clusters.Background
Myb-binding protein 1a (Mybbp1a) was originally identi-
fied as a transcription co-repressor that could bind to the
negative regulatory domain (NRD) the c-myb protoonco-
gene product (c-Myb) [1,2]. Mybbp1a has the LXXLL
motifs that often mediate interactions between nuclear
receptors and their cofactors [3]. Mybbp1a has also been
shown to interact with a number of other transcription
factors, including PGC-1α, RelA/p65, Prep1, Aire, and
CRY1, and exert inhibitory effect on their transactivation
activity [4-9]. These findings are highly suggestive of a
context-dependent co-repressor function of Mybbp1a in
RNA Pol II transcription. In further support of this puta-
tive role, Mybbp1a was recently identified as a component* Correspondence: Ben.Yung@inet.polyu.edu.hk; liu-hsuan@mail.cgu.edu.tw
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reproduction in any medium, provided the orof several co-repressor and ATP-dependent chromatin re-
modeling complexes, including Ret-CoR and esBAF com-
plex [10,11], that mostly contain common constituents
such as HDACs. While the roles of Mybbp1a in these re-
pressor complexes remain unclear, it may likely serve simi-
lar epigenetic and cellular functions. Importantly, Mybbp1a
is also known to preferentially interact with dimethyla-
ted histone H3K9, a marker of transcriptional repression
[4]. Collectively, these observations strongly implicate
Mybbp1a in the epigenetic regulation of gene expression.
Mybbp1a is located mainly within the nucleolus, and
possesses in its carboxyl domain basic-amino-acid repeats
that are responsible for its nuclear and nucleolar local-
ization [12]. However, the exact role of Mybbp1a in the
nucleolus is largely unknown. Its yeast homologue, Pol5p,
was previously reported to be required for ribosomal
DNA (rDNA) transcription [13,14]. Recently, Mybbp1a
was also found to associate with nucleophosmin/B23
(NPM) [15], which is a nucleolar phosphoprotein with
roles in multiple steps of ribosome biogenesis, including
acting as a histone chaperone for chromatin transcription. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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study was to characterize any functional link of Mybbp1a
to ribosomal RNA (rRNA) gene expression.
The nucleolus is a nuclear subcompartment in which
nascent ribosomal RNAs (rRNAs) are synthesized, pro-
cessed and assembled into ribosomes. Transcription of
rRNAs by Pol I is a fundamental step in ribosome bio-
genesis and in determining the protein synthesis capacity
of the cell. Cellular control of this process is thus tightly
coordinated with cellular metabolism and proliferation
[18]. The rRNA genes are tandemly arrayed in hundreds
of copies within nucleolar organizer regions (NORs).
However, both the number and the transcriptional rate
of the rRNA genes actively engaged in transcription may
vary in any given cell and condition, and constitute key
determinant of Pol I transcription regulation [19-21].
Efficient transcription also requires a Pol I-associated
multiprotein complex that encompasses selectively fac-
tor (SL)1 and upstream binding factor (UBF) [22,23].
Chromatin context represents another significant con-
tributory factor on the status of the rDNA clusters,
which can be characterized by two different types of
chromatin – an open, transcriptionally active one, and a
closed one with a repressive state [24]. They are further
distinguishable on the basis of distinct nucleosomal posi-
tioning, histone modifications and DNA methylation.
These epigenetic characteristics are mediated and con-
trolled by the interplay of various chromatin remodelers
and modifiers [19], and, particularly for the inactive
rDNA gene, by a temporal order of NoRC-mediated co-
factor protein binding and enzymatic events [25,26].
Results from our present work are consistent with the
scenario that Mybbp1a is an integral constituent of the
rDNA epigenetic regulation. Mybbp1a acts as a suppres-
sor of rRNA transcription by binding to the chromatin
around the hypermethylated, inactive rDNA gene pro-
moters. Our data showed that Mybbp1a was important
for maintaining the local DNA methylation levels and
histone marks associated with gene silencing. Lack of
Mybbp1a further altered the promoter occupancy of
various factors such UBF and HDACs, consequently
leading to elevated rRNA expression. We propose that
Mybbp1a binding, in association with HDAC1/2, main-
tains rDNA repeats in a silenced state and thus balances
the overall status of rDNA clusters.
Results
Mybbp1a is a repressor of ribosomal RNA gene
expression
Given its nucleolar localization [12], association with
NPM [15], and putative link to RNA Pol I in yeast
[13,14], we set out to investigate the role Mybbp1a in the
production of ribosomal RNA. To this end, we altered the
expression of Mybbp1a by either overexpression or geneknockdown and measured the levels of pre-ribosomal
RNA (pre-rRNA) by quantitative reverse transcriptase-
mediated PCR. We established clones of HeLa cells stably
expressing Mybbp1a-targeting shRNA (Figure 1A). Ex-
pression analysis of rRNA levels revealed significant upre-
gulation (~2 folds) in these cells relative to the control
(Figure 1B, top). Since rRNA transcription is known to be
cell cycle-dependent and coupled to cell growth, we fur-
ther characterized the role of Mybbp1a under different
cell cycle conditions. To this end, elevation in pre-rRNA
levels was similarly observed in cells at different cell cycle
stages (G1/S and mitosis; Figure 1B) or under glucose/
nutrient starvation (Figure 1C). Upregulation of rRNA ex-
pression in the Mybbp1a knockdown cells were similarly
observed by using the Northern blot analysis (Add-
itional file 1 Figure S1A) and nuclear run-on assay
(Additional file 1 Figure S1B), further confirming the alter-
ation in rRNA synthesis rates. Furthermore, the negative
role of Mybbp1a in this functional regard was independently
corroborated in a mouse myoblast cell line, C2C12 (Add-
itional file 1 Figure S1, C & D). In contrast, transient overex-
pression of Mybbp1a led to a moderate but reproducible
reduction in 45 S pre-rRNA levels (Figure 1, D & E, and
Additional file 2 Figure S2A). Notably, a substantial decrease
in nascent pre-rRNA levels was observed when Mybbp1a-
expressing HeLa cells were cultured in a low serum condi-
tion (Figure 1F and Additional file 2 Figure. S2A), under
which rRNA production has been shown to decrease. To-
gether, these results imply that Mybbp1a may be a negative
regulator of Pol I-mediated rRNA expression during cell
growth or in the absence of mitogens.Mybbp1a binds to specific regions of the inactive human
ribosomal DNA
To begin elucidating Mybbp1a function in rDNA tran-
scription, we next explored whether the inhibitory effect
of Mybbp1a occurs in the chromatin context. To do this,
we performed ChIP assay to examine the association of
Mybbp1a with rDNA chromatin in cells. Formaldehyde
cross-linked chromatin from HeLa cells was immuno-
precipitated with anti-Mybbp1a antibody. Quantitative
real-time PCR using primer pair sets that span the entire
human rDNA repeat was done next to obtain a high-
resolution profile (~0.5-1 kb) of Mybbp1a binding
throughout this locus (Figure 2A). Our results subse-
quently showed a distinct binding pattern, with particu-
lar enrichment at the promoter/transcription initiation
site and at the end of the transcribed region (Figure 2, B).
Additional ChIP experiments also pinpointed the bind-
ing of Myc-Mybbp1a to similar regions of the rDNA
locus (Figure 2C). We further focused on the rDNA
promoter region and confirmed binding by end-point
PCR (Figure 2C, bottom).
Figure 1 Mybbp1a negatively regulates the expression of ribosomal RNA. (A) Establishment of the control (ctrl) and Mybbp1a (si-Mybbp1a)
knockdown HeLa stable lines. Expression of Mybbp1a was assessed by Western blot (left) or real-time RT-PCR (right) analysis. Actin serves as the
internal control. (B) qRT-PCR analysis of pre-rRNA expression in control or Mybbp1a knockdown cells derived from proliferating (unsync),
G1/S-arrested (G1/S), or mitotic (M) culture. (C) Control (ctrl) or Mybbp1a (si-Mybbp1a) knockdown cells were incubated in media containing the
indicated glucose concentrations (4500, 1000, or 300 μg/ml) for 24 h. Total RNA was extracted from these cells and analyzed for pre-rRNA
expression using qRT-PCR. (D) HeLa cells were transiently transfected with an empty vector (ctrl) or a construct encoding Myc-Mybbp1a.
Expression of the ectopic Mybbp1a and actin (loading control) was examined by Western blot analysis. (E) & (F) Cells from (D) were cultured in
either normal (E) or serum-free (F) media for 24 h, prior to qRT-PCR analysis of pre-rRNA expression. For bar graphs, data presented are
normalized to GAPDH values, with the mean± SD values from at least three experiments also shown (ns, not significant; *p< 0.05; **p< 0.01).
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or-none occurrence of DNA methylation that is directly
coupled to the transcriptional status [26], we next ana-
lyzed the relationship between Mybbp1a promoter occu-
pancy and rDNA methylation. To address this issue, we
performed the ChIP-chop assay that allows differentiation
between the methylated and unmethylated promoter in
the precipitated DNA (see Methods). In the first step, the
input and precipitated DNA were digested with the iso-
schizomers MspI (methylation-insensitive) or HpaII
(methylation-sensitive). A region of the rRNA promoter
that harbors four HpaII/MspI sites was subsequently amp-
lified by the specific primers (Figure 2D). Using quantita-
tive real-time PCR, the HpaII-resistant PCR productsgenerated from the input and precipitated DNA measures
the level of the methylated rRNA promoter, whereas the
difference between mock-digested and HpaII-digested sig-
nal reflects the level of the rRNA promoters that are
unmethylated. Our results revealed that the DNA methy-
lation levels measured at the promoter was about 60% in
the HeLa cells (Figure 2E). As controls to the experiment,
we also monitored methylation extent of the DNA bound
by PAF49 (a subunit of RNA polymerase I) and a known
repressive mark H4K20me3 (Figure 2E). As expected,
PAF49 was predominantly associated with the non-
methylated promoters, correlating with active transcrip-
tion. Conversely, analysis of the H4K20me3 modification
revealed it distribution with methylated DNA, thus
Figure 2 Preferential association of Mybbp1a with chromatin regulatory region of the methylated, inactive rDNA. (A) Schematic
representation of a single human rDNA repeat. The gene structure and locations of the amplicons (black lines, in kb relative to the transcription
start site) are shown. (B) & (C) ChIP analysis was done to profile Mybbp1a binding on the rDNA gene. Chromatin was prepared from HeLa cells
(B) or HeLa cells transfected with empty vector or a Myc-tagged Mybbp1a-encoding construct (C). Enrichment of rDNA fragments precipitated
with anti-Mybbp1a (B) or anti-Myc (C) antibody was quantitatively analyzed by real-time PCR using primers denoted in (A). For each amplicon,
binding was normalized to the values of either IgG (B) or anti-Myc binding in the control transfection (C). ChIP, followed by end-point PCR
analysis of amplicon 0 (A), was performed to confirm the binding of Mybbp1a to rDNA promoter (bottom). Representative results from one of
three biological replicates are shown. (D) Schematic representation of the rRNA promoter region amplified in the site-specific methylation analysis
and ChIP-chop assays (Primer-F and Primer-R denote respectively the forward and reverse primers) and the locations of HpaII/MspI sites (see
Methods). (E) Quantitative analysis and graphical representation of the association of Mybbp1a, PAF49, and H4K20me3 with rDNA promoter.
ChIP-chop assay was done as described in the Methods. Extent of methylation in the bound promoter rDNA is assessed by signals derived from
the HpaII digestion, and is shown relative to level of unmethylated promoter.
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rRNA promoter immunoprecipitated by anti-Mybbp1a
antibody was mostly HpaII-resistant (Figure 2E), our data
suggest that Mybbp1a is mainly associated with the
methylated promoter. Together, these findings pinpoint
the selective association of Mybbp1a with the inactive
rDNA promoter in the chromatin context and correlate
well with its inhibitory effect on rRNA expression.
Mybbp1a is important for maintaining the epigenetic
status of rDNA promoter
Having established a potential link of Mybbp1a to the
repressed rDNA genes, we next examined whether itssuppression of rDNA transcription is mediated through
a DNA methylation-dependent mechanism. Toward this
end, we monitored the local DNA methylation status of
rDNA promoter in the control vs. knockdown cells.
Equivalent amounts of DNA from these cells were
digested either with the HpaII or Msp1. PCR analysis,
with primers that specifically amplified the region of
rDNA harboring 4 HpaII/MspI sites (Figure 2D),
revealed that ~60% of the rDNA promoters in the con-
trol HeLa cells were methylated (Figure 3A). However,
promoter genomic DNA from Mybbp1a knockdown cells
were more easily digested by HpaII, which was equivalent
to a methylation rate of 36% (Figure 3A). In contrast,
Figure 3 Mybbp1a is important for maintaining rDNA promoter
methylation. (A) & (B) The rDNA promoter was amplified from
undigested (U, uncut), and HpaII- (H) or MspI-digested (M) genomic
DNA from control (ctrl) or Mybbp1a (si-Mybbp1a) knockdown HeLa
cells, and resolved on agarose gel (A). GAPDH promoter and
chromosome 19 were amplified to control for complete restriction
enzyme digestion and input DNA normalization, respectively.
Quantitative analysis of the results in (A) was done using real-time
PCR (B). (C) Quantitative DNA methylation analyses were done as in
(B) with genomic DNA from HeLa cells transfected with control
vector (−) or Myc-Mybbp1a-encoding construct (+). (For statistical
analyses shown in this figure: *p< 0.05).
Figure 4 RNAi depletion of Mybbp1a alters epigenetic status of
rDNA promoters. Mybbp1a regulates the association of RNA Pol I
machinery and histone marks with rDNA promoter. Control (−) and
knockdown (+) cell lines were subjected to ChIP for analyzing
promoter binding of various Pol I components and epigenetic
marks: UBF (A), RPA194 (B), H4ac, H3K9Ac, H3K9me3 and H4K20me3
(C). ChIP was carried out with control (IgG) or the specific
antibodies, as denoted. Quantitative determination of the bound
DNA, carried out with real-time PCR, is depicted by the bar graphs.
Data presented are normalized to IgG values, with the ratio for each
control group set to 1 (*p< 0.05; **p< 0.01).
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increase in rDNA promoter methylation as compared to
the control (Figure 3B), further strengthening the notion
that Mybbp1 may be required for establishing a stable
DNA methylation state of the rDNA promoter region.
Since silencing of inactive rDNA repeats is enforced by
additional epigenetic repressors [27-29], we further
examined Mybbp1a’s role in regulating the overall epi-
genetic attributes of rDNA promoter. Additional ChIP
assays followed by real-time PCR were carried out on the
control and Mybbp1 RNAi cells. Consistent with its
function in suppressing rDNA transcription, knockdown
of Mybbp1a augmented the occupancy of UBF (Figure 4A
and Additional file 3 Figure S3A) and Pol I subunit
RPA194 (Figure 4B and Additional file 3 Figure S3B) at
the promoter and the 3’ end of the rDNA gene. Mybbp1a
depletion also increased the amount of resident histone
acetylation marks on H3K9 and H4, indicative of a chro-
matin environment accessible to transcription machin-
ery. These observations indicate that rDNA promoter
binding of RNA Pol I was promoted in the absence of
Mybbp1a.
By further examining the resident histone modifica-
tions at rDNA promoter, we found that lack of
Mybbp1a led to increase in the levels of H3 (H3K9)and H4 acetylation (Figure 4C). Concomitantly with
the rise of activating marks, abrogation of Mybbp1a also
triggered decline in the levels of rDNA promoter-
associated repressive marks – H3K9me3 and H4K20me3
(Figure 4C). Collectively, these observations strongly
suggest that Mybbp1a is important for the convergence
of epigenetic signals at the repressed rDNA promoters
and consequently the maintenance of its heterochro-
matic features.
Histone deacetylase 1/2 may contribute to
Mybbp1a-mediated rDNA repression
We sought to further dissect the molecular basis of
Mybbp1a’s inhibitory role in rDNA gene transcription.
Given the requirement of HDACs in maintaining an in-
active state of rDNA promoters [26,30], and the reported
association of Mybbp1a with several HDACs-containing
co-repressor complexes [10], we next aimed to assess
whether HDACs contribute to Mybbp1a-mediated
rDNA gene silencing. Toward this end, we first per-
formed a co-immunoprecipitation assay and verified that
Figure 5 Mybbp1a associates with and stabilizes rDNA promoter occupancy of HDAC1/2. (A) Co-immunoprecipitation of HDAC1 and
HDAC2 with endogenous Mybbp1a. Immunoprecipitation (IP) was done with control IgG or antibody against Mybbp1a (M). Immunoprecipiates
and lysate input (Inpt, 1/40 of IP) were probed for HDAC1 and HDAC2. (B) & (C) HDAC1 and HDAC2 binding to the rRNA promoter (amplicon 0
in Figure 2A) were examined in the control (−) and Myc-Mybbp1a-overexpressing (+) HeLa cells (B) or the control (−) and Mybbp1a-knockdown
(+) HeLa cells (C). Chromatin fragments were prepared from these cells and subjected to ChIP with control, HDAC1, or HDAC2 antibody.
Quantitative determination of the bound DNA, carried out with real-time PCR, is shown by the bar graphs. Data presented are normalized to the
IgG values, with the ratio for each control group set to 1 (*p< 0.05; **p< 0.01). (D) Myc-Mybbp1a-overexpressing (Myc-Mybbp1a) HeLa cells were
treated with solvent (−), deacetylase inhibitor TSA, or DNMT inhibitor 5-AzaC, prior to qRT-PCR analysis of pre-rRNA expression. For bar graphs,
data presented are normalized to GAPDH values, with the mean± SD values from at least three experiments also shown (*p< 0.05).
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the exogeneous (Myc-Mybbp1a) or endougenous
Mybbp1a (Figure 5A, and data not shown). Next, ChIP
assays were used to determine whether mis-expression
of Mybbp1a had an effect on HDAC occupancy of the
rDNA promoter. Notably, Mybbp1a overexpression led
to considerably stronger promoter binding of the
HDAC enzymes (Figure 5B). Conversely, such promoter
binding was reduced in the Mybbp1a knockdown cells
(Figure 5C). In addition, we also demonstrated that in-
hibition of HDAC (by trichostatin A, or TSA) or DNMT
(by 5-azacytidine, or 5-AzaC) activity reversed the nega-
tive effects of Mybbp1a overexpression on pre-rRNA ex-
pression (new Figure 5D). Collectively, these findings
thus implicate Mybbp1a in facilitating or stabilizing
HDACs promoter association and consequently the over-
all epigenetic status of the promoter chromatin.
Discussion
In the present study we provided several lines of evi-
dence to demonstrate a role of Mybbp1a in maintaining
the silent state of the rDNA: an association with themethylated rDNA chromatin, the negative regulation of
ribosomal RNA expression, and a regulatory role on
the epigenetic status of the silenced rDNA promoter.
Together with the previous observations that Mybbp1a is
associated NPM, our data reinforced the notion that this
nucleolar protein is directly involved in the production of
rRNA. Our work further uncovered a novel component
of the epigenetic regulatory network that underlies the
balanced state of rDNA clusters.
In spite of previous reports on the potential role of
Mybbp1a in gene regulation, demonstration of its func-
tional significance in cells has been largely elusive. A re-
cent study showed that Mybbp1a is downstream of the
Aurora B kinase signaling and plays an essential role in
the normal progression of mitosis [31]. Furthermore,
Mybbp1a was recently found to signal a response to nu-
cleolar stress by facilitating the p300-dependent acetyl-
ation and activation of p53 [32]. In addition, Mybbp1a
has been linked, via PGC-1α and Prep1, to mitochon-
drial respiration and insulin-mediated glucose uptake in
muscle [6,9], thus strengthening a relevant role of
Mybbp1a in cellular metabolism. Collectively, these
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factor with pleiotropic functions. Our present study pro-
vides further support to this possibility by establishing a
previously unrecognized link of the Mybbp1a protein to
ribosomal RNA expression regulation. Its nucleolar
function may thus underpin proper protein production
and cell proliferation.
Due to tight coordination between ribosome biogen-
esis and cell proliferation and metabolism, transcription
of rRNA and stable maintenance of rDNA clusters are
thought to be under intricate control by intercalated
mechanisms, particularly at the epigenetic level. Various
chromatin remodeling and modifying activities with a
role in rDNA transcription have been identified [19,24].
To such regulatory networks, we have added a new
important one. The observed functional attributes of
Mybbp1a are in accordance with those previously
reported for other rDNA-associated epigenetic repres-
sors, such as JHDM1B [33] and energy-dependent nucle-
olar silencing complex (eNoSC) [34]. Interestingly, an
energy-sensing nucleolar pathway involving eNoSC and
Mybbp1a was recently implicated in the nucleolar
stress-associated regulation of p53 [35]. Possible func-
tional and physical interaction between Mybbp1a and
these factors may thus contribute to a robust and dy-
namic expression of the ribosomal RNA. However, while
an upregulation of rRNA may be accompanied by
greater extent of cellular proliferation and sometimes an
increase in cell size, as shown in the case of JHDM1B,
knockdown of Mybbp1a led to instead a slower cell
growth and slighted delayed G1-S phase progression
(data not shown). This discrepancy may be explained by
the potentially multifunctional nature of Mybbp1a, abro-
gation of which may elicit compensatory changes that
culminate in cell growth arrest and/or defect. In
addition, disturbance of nucleolar content as a conse-
quence of rRNA accumulation may also activate stress
signal cascades that ultimately restrain cell growth.
While a repressor function on rDNA genes has been
ascribed to Mybbp1a by our results, how such role is
manifested remains an unanswered question. Mybbp1a
is known to associate with diverse transcriptional regula-
tors, acting largely as a repressor for Pol II transcription.
In this capacity, Mybbp1a was recently identified as a
component of several HDAC-containing co-repressor
and ATP-dependent chromatin remodeling complexes,
including Ret-CoR and esBAF complex [10,11]. These
enzymatic activities are intimately associated with the
processes of differentiation and stem cell physiology, and
mostly contain common constituents such as HDACs.
Unlike other chromatin remodeling factors, no enzym-
atic activity has been described for Mybbp1a, despite the
presence of several domains that are characteristic of
transcriptional regulators, such as leucine zipper-like,basic, and acidic motifs. Intriguingly, the binding of
Mybbp1a with histone H3 amino terminus that is
dimethylated on the Lys9 residue was demonstrated pre-
viously [4]. These findings thus imply that Mybbp1a may
be capable of recognizing distinct chromatin domains,
particularly the silenced regions, and consequently exert-
ing its regulatory functions. This mode of action may re-
semble that recently documented for the component of
eNoRC, nucleomethylin [34]. Together with the observa-
tions that abrogation of Mybbp1a impaired the rDNA
promoter association of HDACs and DNA methylation,
these attributes may pinpoint the repressor function of
Mybbp1a temporally at a step subsequent to eNoRC but
preceding or concomitant with the recruitment of
HDACs and DNMT to the inactivated promoter. Fur-
thermore, it is a formal possibility that Mybbp1a may
serve as a structural adaptor for the co-repressor com-
plexes, or an enhancer for the rDNA binding and activity
of the various components.
Methods
Cell culture and synchronization
HeLa cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen) supplemented with 10%
heat-inactivated fetal bovine serum (FBS, Invitrogen)
and 100 U/ml penicillin and streptomycin solution
(Invitrogen). Mouse C2C12 myoblast cells were cultured
similarly, except with supplementation of 20% heat-
inactivated FBS. Cells were maintained in a 5% CO2 hu-
midified incubator at 37 °C. Cell cycle synchronization
was done based on a previous report [36]. For M phase
synchronization, subconfluent cells were treated with
200 ng/ml nocodazole for 10 h. Mitotic cells were
harvested through detachment by mitotic shake-off.
Cells were synchronized at the G1/S boundary by
double thymidine block. Cell cycle profiles were moni-
tored by FACS. For inhibition of HDAC and DNMT
activity, cells were treated respectively with 200 nm of
TSA and 5 μM of 5-AzaC for 24 hrs before gene ex-
pression analysis.
RNAi and establishment of stable cell lines expressing the
Mybbp1a-targeting shRNA constructs
Plasmid-based shRNA-expressing constructs (pSuper)
targeting Mybbp1a (5’-GAGACCAAGAAGCGAAAGA-
3’ & 5’-CTGAGTGGGAGCAGCTGAT-3’) and lucifer-
ase (control) were transfected into HeLa cells using
Lipofectamine 2000 reagent (Invitrogen) to obtain stable
lines. Stable clones overexpressing Mybbp1a were estab-
lished using pcDNA3.1 vector encoding Myc-Mybbp1a
[6]. These cells were plated at low density, subjected to
drug selection with 850 μg/ml G418 (Invitrogen), and
clonal colonies were isolated. Several drug-resistant
C2C12 cell lines were established for each construct and
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Mybbp1a protein were determined by immunoblotting.
For transient knockdown of Mybbp1a in HeLa, cells were
transfected with control or a pool of two Mybbp1a-
specific siRNAs with Lipofectamine RNAiMAX (Invitro-
gen). Twenty-five-nucleotide siRNA duplexes (Stealth,
Invitrogen) were designed targeting different regions of
the mRNA: +1718 to +1743 (5’-AGATGATGAG
TACTCTGAAGGAATT-3’); +3135 to +3160 (5’-CCTGA
TGCTCCAGAAGACTCTGTCT-3’).Cell lysate preparation
Cells were harvested and washed twice in PBS. Whole
cell extracts were prepared using WCE buffer [20 mM
HEPES, pH 7.4, 0.2 M NaCl, 0.5% Triton X-100, 10%
glycerol, 1 mM EDTA, 1 mM EGTA, 10 mM β-glycero-
phosphate, 2 mM Na3VO4, 1 mM NaF, 1 mM DTT,
cocktail protease inhibitor (Roche)]. For preparation of
nuclear extracts, cell pellets were resuspended in 1 ml of
lysis buffer (10 mM Tris–HCl pH 7.4, 10 mM NaCl,
3 mM MgCl2, 0.5% NP-40 and cocktail protease inhibi-
tor) per 107 cells. After 10-min incubation on ice, nuclei
were collected by centrifugation (500 g, 5 min) and
washed with lysis buffer devoid of NP-40. After centrifu-
gation, the pellet was resuspended in 100 μl nuclei lysis
buffer (10 mM Tris–HCl pH 7.4, 400 mM NaCl, 1 mM
EDTA, 1 mM DTT and cocktail protease inhibitor),
mixed thoroughly for 30 min at 4 °C. The nuclei lysates
were diluted 10-fold in WCE buffer and centrifuged
(16000 g, 20-min, 4 °C) to obtain the nuclear fraction.
Lysates were boiled in 2X urea sample buffer dye
(100 mM Tris–HCl, pH 6.8, 4% SDS, 0.2% bromophenol
blue, 20% glycerol, 200 mM β-mercaptoethanol, 8 M
urea), and fractionated by SDS-PAGE.Reagents and antibodies
All chemicals were purchased from sigma (St. Louis,
MO), except where otherwise indicated. Mybbp1a spe-
cific antibody (Cell Signaling Technology; Danvers, MA.
USA) was raised in rabbit using a recombinant protein
corresponding to amino acids 1092–1214 of mouse
Mybbp1a, followed by antigen-specific purification.
Anti-Myc-tag monoclonal antibody was from Cell Sig-
naling Technology (Danvers, MA. USA). β-actin specific
monoclonal antibody and polyclonal antibodies against
HDAC1, HDAC2, H3K9me3, H4ac were from Millipore
(Temecula, CA, USA). αH3K9Ac, αH3K9Me2, αSuv39h1,
αSWI/SNF, and αPCAF rabbit polyclonal antibodies were
purchased from Abcam (Cambridge, MA, USA). Anti-
PAF49/CAST antibody was obtained from Bethyl Labora-
tories (Montgomery, TX, USA). Secondary antibodies
used in the Western blot assays were from Vector La-
boratories (Burlingame, CA, USA), whereas those used inimmunofluorescence analysis were obtained from
Invitrogen.
Western blot analysis and immunoprecipitation
Western blot analysis was performed after electrophor-
etic separation of polypeptides by 7.5 or 12.5% SDS-
PAGE and transfer to Immobilon-P/PVDF membranes
(Millipore). Blots were probed with the indicated pri-
mary and appropriate secondary antibodies. Immuno-
bands were subsequently detected by the enhanced
chemi-luminescence reaction (ECL) (PerkinElmer; Wal-
tham, MA, USA). All immunoprecipitations were per-
formed with equal amounts of cell extract protein
(1 mg) incubated with the indicated antibodies (2.5 μg)
at 4 °C for overnight. The immunocomplexes were cap-
tured with protein G-sepharose (Millipore) for 1 hr at
4 °C with rotation. The protein G-antigen-antibody com-
plexes were washed six times with the WCE buffer, and
boiled in 2X sample buffer dye for subsequent PAGE
and immunoblotting analysis as described above.
RNA isolation and reverse transcription (RT)-PCR
Total RNA from cells was isolated using the TRIzol re-
agent (Invitrogen) according to the manufacturer’s
instructions. Genomic DNA was removed by digestion
with 2U of DNase I (Ambion; Foster City, CA, USA).
cDNA was synthesized by MMLV reverse transcriptase
(Invitrogen) using random hexamers. Quantitative deter-
mination of the cDNA levels was done by real-time PCR
using the Bio-Rad iQ5 Gradient Real Time SYBR-Green
PCR system. Levels of cDNA were normalized to the
GAPDH values of the respective samples. All results rep-
resent the mean ± SD of at least three independent
experiments. Sequences of the primers are listed in Add-
itional file 4 Table S1.
Northern blot analysis and nuclear run-on assay
Additional methods for measuring the rRNA transcrip-
tion rate – Northern blot analysis and nuclear run-on
assay – were performed as essentially described else-
where [37,38], with some modifications. For the nuclear
run-on assay, we used Digitonin (40 mg/ml; Sigma) in
place of NP-40 to permeabilize cells. Cells were washed
twice with ice-cold 1X PBS and removed from the cul-
ture plate using a cell scraper in 1 ml of 1X PBS per
10-cm dish and collected by centrifugation (500 g,
5 min). Cell pellets were resuspended in 1 ml of lysis
buffer (10 mM Tris–HCl, pH 7.4, 10 mM NaCl, 3 mM
MgCl2, 40 mg/ml Digitonin) per 10
7 cells. After 10-min
incubation on ice, nuclei were then collected by centri-
fugation (500 g, 5 min) and washed with lysis buffer de-
void of Digitonin. To perform run-on reactions,
aliquots of nuclei were mixed with 100 ml of 2X reac-
tion buffer (20 mM Tris–HCl pH 8.0, 5 mM MgCl2,
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CTP and GTP, 200 mM sucrose and 20% glycerol) and
biotin-16-UTP (Epicentre) in a final volume of 200 ml
at 29 °C for 30 min. A total of 60U of RNase-free
DNaseI (Fermentas; Burlington, Ontario, Canada) and
6 ml of 250 mM CaCl2 were added, and the reaction
mixture was incubated for an additional 10 min at 37 °
C. Biotinylated RNA was purified by Dynabeads M-280
(Invitrogen), a magnetic bead covalently linked to
streptavidin. Dynabeads resuspended in binding buffer
(10 mM Tris–HCl, pH 7.5, 1 mM EDTA and 2 M
NaCl) were mixed to an equal volume of run-on RNA
and subjected a 2-hr incubation at room temperature.
Beads were separated by the magnetic apparatus and
washed once with 500 ml 2X SSC-15% formamide for
10 min and twice with 1 ml 2X SSC for 5 min each.
Random hexamer-primed cDNA was synthesized using
10 ml biotinylated RNA, and subsequently subjected to
semi-quantitative PCR to assay for 45 S pre-rRNA
transcription rate. To ensure the efficiency of the re-
verse transcription, the intensities of PCR products
were normalized to those of GAPDH. Generation of
the probe for the Northern blot analysis was based on
the previous report [38].
Chromatin immunoprecipitation (ChIP) and real-time PCR
analysis
ChIP assay was performed essentially as described previ-
ously [39]. Crosslinked, sonicated chromatin was pre-
cleared before being incubated with 2.5 μg of the
indicated antibodies and rotated at 4 °C overnight. Nor-
mal mouse or rabbit IgG (Millipore) was used for the
mock immunoprecipitation. After extensive washes,
immunocomplexes were treated with Proteinase K and
decrosslinked. Bound DNA in the precipitates, as well as
input DNA (1/10 fragmented chromatin), was extracted,
purified, and subjected to real-time PCR analysis using
primers corresponding to different regions of the rDNA
repeat unit. Real-time PCR reactions were conducted on
the Bio-Rad iQ5 Gradient Real Time PCR system, using
the 2X SYBR Green Master mix (Bio-Rad, USA). Results
were corrected for nonspecific binding to IgG and pre-
sented as percentage of input DNA. Triplicate PCRs
for each sample were carried out. The ChIP primer
sequences are listed in Additional file 4 Table S2.
rDNA promoter site-specific methylation analysis
Genomic DNA was isolated from the HeLa cells by
using QIAamp DNA Mini kit (QIAGEN). 5 μg of DNA
were digested overnight with methylation-sensitive
(HpaII) or methylation-insensitive (MspI) restriction
enzymes. Subsequently, rDNA promoter (HrDNA
42.9 kb) was amplified from undigested and HpaII/
MspI-digested genomic DNA. GAPDH promoter and achromosome 19 fragment were also amplified as con-
trols respectively for complete enzyme digestion and
equal DNA input. The primer sequences for GAPDH pro-
moter are as described elsewhere [40], and primer sequences for
the human chromosome 19 region are as follows: Forward,
5’-CTATGCCAAGCCCATTCTAGGTCCT-3’; Reverse, 5’-
GCAGGGAAACTGTGCACAGCAAGAG-3’. For quantitative
analysis, real-time PCR was also performed.Methylation-sensitive ChIP-chop assay
The ChIP-chop experiment was done based on previous
reports [40,41]. To distinguish between the methylated
and unmethylated promoter, the input and precipitated
DNA of the ChIP samples were digested with the iso-
schizomers MspI or HpaII prior to quantitative real-time
PCR analysis. The digests along with an equal amount of
the undigested immunoprecipitated DNA were amplified
as described above. Oligonucleotide sequences and
quantitative PCR assay characteristics are shown in Add-
itional file 4 Table S2. The HpaII-resistant PCR product
generated from the input DNA measures the level of
methylated rRNA promoter, whereas the difference be-
tween mock-digested and HpaII-digested signal reflects
the level of the unmethylated rRNA promoters. The
results were depicted as the ratio of methylated to
unmethylated DNA precipitated with the antibodies in
the ChIP.Additional files
Additional file 1: Figure S1. Independent confirmation of the negative
role of Mybbp1a in rRNA expression (related to Figure 1, B to F). (A) Total
RNA was extracted from control and Mybbp1a knockdown (si-Mybbp1a)
cells. The levels of 47 S pre-rRNA as well GAPDH (as a control) were
analyzed in a northern blot probed with a dig-labeled DNA probe. (B)
Nuclear run-on assay was performed as described in the Methods, on the
control (−) and Mybbp1a-knockdown (+) HeLa cells. (C) & (D) Mouse
C2C12 myoblast cells were transfected with control (−) or Mybbp1a-
targeting (+) siRNA for 48 hrs. Total RNA was then prepared for
expression analysis. Extent of Mybbp1a downregulation was assessed by
real-time RT-PCR analysis (C). Expression of pre-rRNA was analyzed also by
quantitative RT-PCR (D). For bar graphs, data presented are normalized to
GAPDH values, with the mean ± SD values from at least three
experiments also shown (**p< 0.01; ***p< 0.001).
Additional file 2: Figure S2. Cell cycle profiles of the cells in
Figure 1, E & F. Cells transiently harboring control (ctrl) or Myc-
Mybbp1a-expression plasmid were subjected to flow cytometry analysis
for measurement of DNA content. Cells in the G1, S, and G2/M phases
were defined by gating. Percentages of gated events are summarized
on the right.
Additional file 3: Figure S3. Mybbp1a regulates the association of
RNA Pol I machinery with rDNA gene (related to Figure 4, A & B).
Control (ctrl) and knockdown (si-Mybbp1a) cell lines were subjected to
ChIP for analyzing promoter binding of UBF (A) and RPA194 (B). ChIP
was carried out with control (IgG) or the specific antibodies, as
denoted. Quantitative determination of the bound DNA, carried out
with real-time PCR, is depicted by the bar graphs. Primers
corresponding to various regions of the rDNA gene, as denoted in
Figure 2A, were used. Data presented are normalized to IgG values,
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*p< 0.05; **p< 0.01; ***p< 0.001).
Additional file 4: Table S1. Primers for quantitative RT-PCR. Table S2.
Primers for ChIP assay.
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